Applicability of the Framingham Risk Score in predicting mortality among kidney failure patients: an international analysis
A higher FRS associated with similar increases in mortality risk in three distinctly different cohorts of ESRD patients, whereas the addition of non-traditional risk factors had a negligible impact. The FRS is a valid tool for estimation of mortality risk in ESRD patients.
Authors
- Bengt Lindholm (ORCID: https://orcid.org/0000-0003-4269-4293)
- Xiejia Li (ORCID: https://orcid.org/0000-0002-8163-814X)
- Abdul Rashid Qureshi (ORCID: https://orcid.org/0000-0003-0536-5327)
- Peter Stenvinkel (ORCID: https://orcid.org/0000-0002-8785-4820)
- Olof Heimbürger (ORCID: https://orcid.org/0000-0003-0901-4145)
- Peter Bárány (ORCID: https://orcid.org/0000-0001-6501-8293)
- Rending Wang (ORCID: https://orcid.org/0000-0002-2063-8533)
- Zhimin Chen (ORCID: https://orcid.org/0000-0003-3942-9579)
- Jianghua Chen
- Hong Jiang (ORCID: https://orcid.org/0000-0003-2222-0816)
Institutions
- Central South University (CN)
- Karolinska Institutet (SE)
- Baxter (Sweden) (SE)
- Second Xiangya Hospital of Central South University (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1093/ckj/sfaf296
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- National Natural Science Foundation of China
- Karolinska Institutet
- Vetenskapsrådet
- Zhejiang University
- Njurfonden